Over the years, different target proteins such as ezrin61, IQGAP174, non-muscle myosin IIA23 or proteins related to the tissue plasminogen activator pathway75 have been shown to act as S100P binding partners in normal and cancer cells where they are believed to regulate motility and invasion. The gene discussed is S100P; the disease is cancer.